Compounds > l 741626
Page last updated: 2024-09-04

l 741626 and gr 218231

l 741626 has been researched along with gr 218231 in 3 studies

Compound Research Comparison

Studies
(l 741626)		Trials
(l 741626)		Recent Studies (post-2010)
(l 741626)		Studies
(gr 218231)		Trials
(gr 218231)		Recent Studies (post-2010) (gr 218231)
76033600

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audinot, V; Cussac, D; Dubuffet, T; Gobert, A; Lavielle, G; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Rivet, JM1
Brocco, M; Dekeyne, A; Dubuffet, T; Lavielle, G; Millan, MJ; Rivet, JM1
Arnt, J; Bétry, C; Etievant, A; Haddjeri, N1

Other Studies

3 other study(ies) available for l 741626 and gr 218231

ArticleYear
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: Animals; Benzopyrans; Brain; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enzyme Activation; Guanosine 5'-O-(3-Thiotriphosphate); Indoles; Male; Mitogen-Activated Protein Kinases; Norepinephrine; Oxazines; Piperidines; Pyrroles; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Serotonin; Sulfones; Tetrahydronaphthalenes

2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: Animals; Behavior, Animal; Benzopyrans; Body Temperature; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Extrapyramidal Tracts; Indoles; Male; Mice; Motor Activity; Oxazines; Piperidines; Psychotropic Drugs; Pyrroles; Rats; Rats, Wistar; Receptors, Dopamine D3; Sulfones; Tetrahydronaphthalenes

2000
Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Neuroscience letters, 2009, Aug-21, Volume: 460, Issue:1

    Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Indoles; Male; Neurons; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulfones; Tetrahydronaphthalenes; Ventral Tegmental Area

2009